Risk factors for NAION: Age (usually affects people over 50) Diabetes Hypertension High cholesterol Sleep apnea Anatomical predispositions (such as a small cup-to-disc ratio) Symptoms of NAION include sudden vision loss in one eye (ranging from mild to severe), missing portions of vision (visual field defects), and disc swelling
Adverse events can be reported to the FDA through its MedWatch program to help protect public health
The FDA has approved branded versions of these medications (Wegovy, Ozempic, Mounjaro, Zepbound) for specific indications, but compounded versions are legally distinct products prepared by compounding pharmacies under federal and state regulations
0.25 mg for the first four weeks
Many users on social media report feeling fuller after drinking oatzempic which is not surprising
[80] were able to show how both topical and systemic liraglutide administration prevented retinal degeneration in db/db mice